Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prestige Consumer Healthcare (PBH) Enterprise Value (2016 - 2026)

Prestige Consumer Healthcare has reported Enterprise Value over the past 16 years, most recently at -$62.4 million for Q4 2025.

  • For Q4 2025, Enterprise Value fell 22.6% year-over-year to -$62.4 million; the TTM value through Dec 2025 reached -$62.4 million, down 22.6%, while the annual FY2025 figure was -$97.9 million, 110.64% down from the prior year.
  • Enterprise Value for Q4 2025 was -$62.4 million at Prestige Consumer Healthcare, up from -$119.1 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$21.0 million in Q4 2021 and troughed at -$163.6 million in Q2 2021.
  • A 5-year average of -$64.5 million and a median of -$53.1 million in 2023 define the central range for Enterprise Value.
  • On a YoY basis, Enterprise Value climbed as much as 78.08% in 2022 and fell as far as 310.88% in 2022.
  • Year by year, Enterprise Value stood at -$21.0 million in 2021, then plummeted by 310.88% to -$86.4 million in 2022, then increased by 26.34% to -$63.6 million in 2023, then increased by 20.03% to -$50.9 million in 2024, then decreased by 22.6% to -$62.4 million in 2025.
  • Business Quant data shows Enterprise Value for PBH at -$62.4 million in Q4 2025, -$119.1 million in Q3 2025, and -$139.5 million in Q2 2025.